Similarly, LKB1 loss correlated significantly with the KC co-mutational status, since 24% (12/51) of KC tumors exhibited LKB1 loss versus the 9% (4/6) of KCs that yielded intact LKB1 expression; (p < 0.001). The gene discussed is CALCA; the disease is keratoconus.